Bioequivalence trials for the approval of generic drugs in Saudi Arabia: a descriptive analysis of design aspects.

Turki Abdulaziz AlthunianBader R AlzenaidyRaseel A AlrobaOhoud A AlmadaniFahad A AlqahtaniAlbatool A BinajlanAmal I AlmousaDeema K AlamrMalak S Al-MofadaNora Y AlsaqerHessa A AlarfajAbdulmohsen A BahlewaMohammed A AlharbiAli M AlhomaidanAbdulaziz A AlsuwyehAbdulmohsen A Alsaleh

Published in: BMC medical research methodology (2024)

This comprehensive analysis provides valuable insights into the regulatory and design aspects of bioequivalence trials and can inform future research and assist in identifying opportunities for improvement in conducting bioequivalence trials in Saudi Arabia.

Keyphrases

current status
drug induced